Home Illinois Cancer Center at Illinois Scientists Discover New Breast Cancer Treatment

Cancer Center at Illinois Scientists Discover New Breast Cancer Treatment

An estimated 70% of women diagnosed with breast cancer have ER-positive (ER+) breast cancer. Cancer Center at Illinois researchers are leading the science behind a new global licensing agreement between Bayer AG and Systems Oncology for a new breast cancer compound called ERSO. Developed by the laboratories of Paul Hergenrother, chemistry professor, and David Shapiro, biochemistry professor, ERSO has been shown to target breast cancer cells that express the estrogen receptor.

Their research was the first to show that the compound can effectively target and kill certain cancer cells, especially ER+ breast cancer cells. According to Hergenrother, these breast cancer cells are very sensitive to ERSO, which kills the cells rapidly.

“To have a major company, like Bayer, decide to license ERSO speaks volumes about the societal impact Illinois research can have,” said Hergenrother, who is also the deputy director of the Cancer Center at Illinois.

Announcement

[Illinois] Apply by Friday, May 27th

We have several position openings at the Y’s New American Welcome Center. If you are interested in applying, please submit your resume...

[Urbana] Free fitness events all summer at Meadowbrook Park!

Be sure to join us for FREE Yoga in the Park Saturdays beginning June 11. We will also offer...

[Urbana] Crystal Lake Park Family Aquatic Center opens May 28!

Time to break out the sun screen and head to our outdoor pool! Open swim daily, plus lap...

[Urbana] Boating is Back at Crystal Lake Park!

After two years off, boating is back at Crystal Lake Park. Rent paddle boats, canoes and kayaks starting at $9 for a...